Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung CancerAlexander Drilon, Vivek Subbiah, Kadoaki Ohashi et al.|New England Journal of Medicine|2020Cited by 835
Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven CancersVivek Subbiah, Erica Evans, Justin F. Gainor et al.|Cancer Discovery|2018Cited by 392
A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancerElena Garralda, Gerald S. Falchook, Ammar Sukari et al.|ESMO Open|2022Cited by 87
Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee surveySusana Banerjee, Solange Peters, Urania Dafni et al.|ESMO Open|2018Cited by 77
The British Journal of PsychiatryThomas Fahy, Michael King, Dinesh Bhugra et al.|The British Journal of Psychiatry|2006Cited by 66